11 Recruiting Pancreatic Cancer Clinical Trials in Arizona
Explore active pancreatic cancer research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Pancreatic Cancer Studies in Arizona
🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
📍 The University of Arizona Cancer Center-North Campus — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Pancreatic Cancer Detection Consortium
📍 Translational Genomics Research Institute — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
📍 HonorHealth Medical Group — Scottsdale, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔ 🟡 Not Yet Recruiting Early Phase1 💊 Investigational Drug / Biologic
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
📍 NGM Clinical Study Site — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
📍 Honor Health Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔ RECRUITING Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
📍 University of Arizona Cancer Center - North Campus — Tucson, Arizona
View Study & Checklist ➔